Kate joined CellCentric in March 2021.
Kate is a Human Biology graduate with more than 12 years’ clinical trials operations experience across large pharma, CROs and academic research.
During 9 years at AstraZeneca, Kate managed the delivery of trials across early and late phase oncology programs, led delivery of investigator sponsored oncology trials and was a Regulatory Affairs Manager working with the international markets. As a Clinical Project Manager for DOCS at Amgen, Kate led the delivery and management of cardiovascular investigator sponsored trials. Prior to joining CellCentric, Kate was responsible for the set-up, management and delivery of musculoskeletal and pain trials at Keele University.